Helicobacter pylori and gastric cancer

American Journal of Medicine

Volumn 106, Issue 2, 1999, Pages 222-226

  Scheiman, James M ^a   Cutler, Alan F ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; STOMACH MUCOSA;

EID: 0033082208     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00393-3     Document Type: Review

References (55)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Schistosomes, Liver Flukes and Helicobacter pylori. Infection with Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 61. Lyon, France: International Agency for Research on Cancer. 1994;177-240.
2. Howson C.P., Hiyama T., Wydner E.L. The decline in gastric cancer; epidemiology of an unplanned triumph. Epidemiol Rev. 8:1986;1-27.
3. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence frequency of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
4. Nomura A., Stemmermann G.N., Chyou P., Kato I., Perez-Perez G.I., Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. NEJM. 325:1991;1132-1136.
5. Parsonnet J., Friedman G.D., Vandersteen D.P., et al. Helicobacter pylori infection and the risk of gastric carcinoma. NEJM. 325:1991;1127-1131.
6. Forman D., Newell D.G., Fullerton F., et al. Association between infection with Helicobacter pylori and the risk of gastric cancer. BMJ. 302:1991;1302-1305.
7. Forman D., Webb P., Parsonnet J. Helicobacter pylori and gastric cancer. Lancet. 343:1994;243-244.
8. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet. 341:1993;1359-1362.
9. Parsonnet J., Hansen S., Rodriguez L., et al. Helicobacter pylori infection and gastric lymphoma. NEJM. 330:1994;1267-1271.
10. Eck M., Schmausser B., Haas R., Greiner A., Czub S., Muller-Hermelink H.K. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology. 112:1997;1482-1486.
11. Wotherspoon A.C. Gastric MALT lymphoma and Helicobacter pylori. Yale J Biol Med. 69:1997;61-68.
12. Wotherspoon A.C., Doglioni C., Diss T.C., et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 342:1993;575-577.
13. Neubauer A., Thiede C., Morgner A., et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Nat Canc Inst. 89:1997;1350-1355.
14. Huang J.Q., Sheldon A., Hunt R.H. Is there a causal relationship between H. pylori infection and gastric maltoma? A meta-analysis of evidence from epidemiological studies and clinical trials. Gut. 41:(suppl 1):1997;A49-04/179.
15. Soll A.H. Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology. JAMA. 275:1996;622-629.
16. The European Helicobacter pylori Study Group (EHPSG). Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report. Gut. 41:1997;8-13.
17. Hansson L.E., Nyren O., Hsing A.W., et al. The risk of stomach cancer in patients with gastric cancer or duodenal ulcer disease. NEJM. 335:1996;242-249.
18. Cheli R., Giacosa A. Atrophic gastritis. Sherlock P., Morson B.C., Barbara L., Veronesi U., Precancerous Lesions for the Gastrointestinal Tract. 1983;55 Raven Press, New York.
19. You W.C., Blot W.J., Li J.Y., et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res. 53:1993;1317-1321.
20. Walker I.R., Strickland R.G., Ungar B., Mackay I.R. Simple atrophic gastritis and gastric cancer. Gut. 12:1971;906-911.
21. Cheli R., Santi L., Ciancamerla G., et al. A clinical and statistical follow-up study of atrophic gastritis. Am J Dig Dis. 18:1973;1061.
22. Siurala M., Isokoski M., Varis M., et al. Prevalence of gastritis in a rural population bioptic study of subjects selected at random. Scand J Gastroenterol. 3:1968;211.
23. Kuipers E.J. Helicobacter pylori and the risk and management of associated diseases gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther. 11:(suppl 1):1997;71-88.
24. Correa P. Chronic gastritis a clinico-pathological classification. Am J Gastroenterol. 83:1988;504-509.
25. Asaka M., Kimura T., Kudo M., et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 102:1992;760-766.
26. Forman D., Sitas F., Newell D.G., et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer. 46:1990;608-611.
27. Correa P., Fox J., Fontham E., et al. Helicobacter pylori and gastric carcinoma serum antibody prevalence in populations with contrasting cancer risks. Cancer. 66:1990;2569-2574.
28. Graham D.Y., Malaty H.M., Evans D.G., et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology. 100:1991;1495-1501.
29. Craanen M.E., Dekker W., Blok P., Ferwerda K., Tytgat G.N. Intestinal metaplasia and Helicobacter pylori an endoscopic bioptic study of the gastric antrum. Gut. 2:1992;16-20.
30. Boland C.R., Scheiman J.M. Tumors of the stomach. Yamada T., Textbook of Gastroenterology. 1996;1494-1523 JB Lippincott, Philadelphia.
31. Holcombe C. Helicobacter pylori the African enigma. Gut. 33:1992;429-431.
32. Sierra R., Munoz N., Pena A.S., et al. Antibodies to Helicobacter pylori and pepsinogen levels in children in Costa Rica. Cancer Epidemiol Biomark Prevent. 1:1992;449-1454.
33. Parsonett J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am. 22:1993;89-104.
34. Steer H.W. The gastro-duodenal epithelium in peptic ulceration. J Pathol. 146:1985;355-362.
35. Alkout A.M., Blackwell C.C., Weir D.M., et al. Isolation of a cell surface component of Helicobacter pylori that binds H type 2, Lewis (a) and Lewis (b) antigens. Gastroenterology. 112:1997;1179-1187.
36. Mobley H.L., Cortesia M.J., Rosenthal L.A.E., Jones B.D. Characterization of urease from Campylobacter pylori from gastric biopsies. Am J Clin Pathol. 26:1988;831-836.
37. Tsujii M., Kawano S., Tsuji S., et al. Ammonia a possible promotor in Helicobacter pylori-related gastric carcinogenesis. Cancer Lett. 65:1992;15-18.
38. Wright P.A., Williams G.T. Molecular biology and gastric carcinoma. Gut. 34:1993;145-147.
39. Tahara E. Molecular mechanisms of stomach carcinogenesis. J Cancer Res Clin Oncol. 119:1993;265-272.
40. Horii A., Nakatsuru S., Miyoshi Y., et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 52:1992;323-3233.
41. Martin H.M., Filipe M.I., Morris R.W., et al. P53 expression and prognosis in gastric carcinoma. Int J Cancer. 50:1992;859-862.
42. Recavarren-Arce S., Leon-Barua R., Cok J., et al. Helicobacter pylori and progressive gastric pathology that predisposes to gastric cancer. Scand J Gastroenterol. 181:(suppl):1991;51-57.
43. Borody T.J., Andrews P., Jankiewicz E., Ferch N., Carroll M. Apparent reversal of early gastric mucosal atrophy after triple therapy of Helicobacter pylori. Am J Gastroenterol. 88:1993;1266-1268.
44. Hack H.M., Fennerty M.B., Sampliner R., et al. Reversal of intestinal metaplasia after treatment of H. pylori infection. Gastroenterol. 106:1994;A87.
45. Genta R.M., Lew G.M., Graham D.Y. Change in the gastric mucosa following eradication of Helicobacter pylori. Modern Pathol. 6:1993;281-289.
46. Uemura N., Mukai T., Okamoto S., et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomark Prevent. 6:1997;639-642.
47. Jankiewicz K., Louw J.A., Marks I.N. Long-term histological consequences of suppression/eradication of Helicobacter pylori in antral mucosa. Eur J Gastroenterol Hepatol. 5:1993;701-705.
48. Witteman E.M., Mravunac M., Becx M.J.C.M., et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol. 48:1995;250-256.
49. Borody T.J., Clark I.W., Andrews P., Hugh T.B., Shortis N.P. Eradication of Helicobacter pylori may not reverse severe gastric dysplasia. Am J Gastroenterol. 90:1995;498-499.
50. JY Sung, SR Lin, JYL Ching, et al. Effects of curing Helicobacter pylori infection on precancerous gastric lesions: one-year follow-up of a prospective randomized study in China. Gastroenterology. 1998;114:A296. Abstract.
51. Genta R.M. Helicobacter pylori, inflammation, mucosal damage, and apoptosis pathogenesis and definition of gastric atrophy. Gastroenterology. 113:1997;S51-S55.
52. Parsonnet J., Harris R.A., Hack H.M., Owens D.K. Modeling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer a mandate for clinical trials. Lancet. 348:1996;150-154.
53. Tsugawa M., Shachter R., Owens D.K., Parsonette J. Cost-effectiveness of vaccine development for H. pylori using the Institute of Medicine model. Gastroenterology. 114:1998;A313.
54. Fendrick AM, Chernew ME, Hirth RA, Scheiman JM. Clinical and economic effects of H. pylori screening to prevent gastric cancer. Arch Int Med. In press.
55. Kuipers E.J., Lundell L., Klinkenberg-Knol E.C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. NEJM. 335:1996;1018-1022.